Spruce Capital Partners
Venture capitalSouth San Francisco · Series A–Series B · 3 people tracked
Investment thesis
Spruce Capital Partners creates, advises and invests in innovative life sciences companies focused on positive environmental impacts and improvements to human health and wellness.
Source: firm website, verified Jul 21, 2026.
Team · 3 people
from the firm's websiteWhat they invest in
from 3 of 10 portfolio companiesAgTech ×3Biotech ×2Impact & Social Good ×1
HQs:United States×1
Investments · 10 tracked
founders shown can be your intro pathCropCoat produces a nontoxic coating solution for crops that leaves no residue and does not affect crop quality or taste, designed for growers seeking safer alternatives with no tolerance restrictions for export.
AgTech
GreenLight Biosciences develops RNA-based solutions for agriculture and pest control, including a Colorado potato beetle bio-insecticide and a Varroa destructor mite-control product for sustainable food production.
AgTechBiotechImpact & Social Good
Pivot Bio develops agricultural innovations focused on transforming farming practices through microbiology and genetics. The company serves farmers worldwide.
AgTechBiotech
Board seats · per SEC filings
what is this? ⓘ$8.3M raise · filed Feb 2021 · via Ganesh Kishore, Roger Wyse
Inferred from directors named on each company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does Spruce Capital Partners invest at?
- Spruce Capital Partners invests at the Series A, Series B stages.
- What sectors does Spruce Capital Partners focus on?
- Spruce Capital Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Spruce Capital Partners located?
- Spruce Capital Partners is headquartered in South San Francisco, US.
Images
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.